Unchanged G-Protein-Coupled Receptor Kinase Activity in the Aging Human Heart

Journal of the American College of Cardiology

Volumn 42, Issue 8, 2003, Pages 1487-1492

  Leineweber, Kirsten ^a   Klapproth, Stefan ^a   Beilfuß, Anja ^a   Silber, Rolf Edgar ^b   Heusch, Gerd ^a   Philipp, Thomas ^a   Brodde, Otto Erich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE; RHODOPSIN;

ADULT; AGED; AGING; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFANT; MALE; PHOSPHORYLATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0142012067     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)01063-5     Document Type: Article

References (33)

1. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993;73:413-67.
2. Ferrara N, Davia K, Abete P, Rengo F, Harding SE. Alterations in beta-adrenoceptor mechanisms in the aging heart: relationship with heart failure. Aging Clin Exp Res 1997;9:391-403.
3. Brodde O-E, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999;51:651-89.
4. Brodde O-E, Zerkowski H-R, Schranz D, et al. Age-dependent changes in the beta- adrenoceptor-G protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol 1995;26:20-6.
5. 1-adrenergic receptors in the failing human heart. Circulation 1993;87: 454-63.
6. Iaccarino G, Koch WJ. Therapeutic potential of G protein coupled receptor kinases in the heart. Exp Opin Invest Drugs 1999;8:545-54.
7. Penn RB, Pronin AN, Benovic JL. Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 2000;10:81-9.
8. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 1993;21:498-503.
9. Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature 1976;261:333-5.
10. 1) in the human heart. J Am Coll Cardiol 2002;16:1459-65.
11. Leineweber K, Hoffmann-Heinroth I, Pönicke K, Abraham G, Osten B, Brodde O-E. Cardiac beta-adrenoceptor desensitisation due to increased beta-adrenoceptor kinase in chronic uremia. J Am Soc Nephrol 2002;13:117-24.
12. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
13. 4. Nature 1970;227:680-5.
14. Reissner AH, Nemes P, Buchholtz C. The use of coomassie brilliant blue G-250 perchloric acid solution for staining in electrophoresis and isoelectric focusing on polyacrylamide gels. Anal Biochem 1975;64: 509-16.
15. Brodde O-E, Konschak U, Becker K, et al. Cardiac muscarinic receptors decrease with age: in vitro and in vivo studies. J Clin Invest 1998;101:471-8.
16. Harding SE, Jones SM, O'Gara P, del Monte F, Vescovo G, Poole-Wison PA. Isolated ventricular myocytes from failing and non-failing human heart: the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 1992;24:549-64.
17. Davies CH, Ferrara N, Harding SE. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovasc Res 1996;31:152-6.
18. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation 1994;90:1225-38.
19. 1-adrenergic stimulation. Hypertension 1999;33 pt. II:396-401.
20. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension 1988;5:86-99.
21. Folkow B, DiBona GF, Hjemdahl P, Toren PH, Wallin BG. Measurements of plasma norepinephrine concentrations in human primary hypertension. Hypertension 1983;5:399-403.
22. Esler MD, Turner AG, Kaye DM, et al. Aging effects on human sympathetic neuronal function. Am J Physiol 1995;268:R278-85.
23. Esler M, Skews H, Leonard P, Jackman G, Bobik A, Korner P. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci (London) 1981;60:217-9.
24. Francis GS, Goldsmith SR, Cohn JN. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J 1982;104:725-31.
25. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
26. 2-adrenergic receptor desensitization. J Biol Chem 1990; 265:3202-9.
27. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J 1990; 4:2881-9.
28. 2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 1998;101: 1273-82.
29. De Blasi A, Parruti G, Sallese M. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes: selective increase of beta-adrenergic receptor kinase 1 and 2. J Clin Invest 1995;95:203-10.
30. Pitcher JA, Inglese J, Higgins JB, et al. Role of beta-gamma-subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 1992;257:1264-7.
31. Premont RT, Koch WJ, Inglese J, Lefkowitz RJ. Identification, purification, and characterization of GRK5, a member of the family of G protein receptor coupled kinases. J Biol Chem 1993;268: 23735-8.
32. Ungerer M, Parruti G, Böm M, et al. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 1994;74:206-13.
33. s-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy. J Cardiovasc Pharmacol 1998;31:585-94.